stella
beta
Phase III Adaptive Adaptive Stereostactic Body Radiotherapy (SBRT) With Dose Escalation for High-Risk Prostate Cancer — Stella
Home
/
High Risk Prostate Cancer
/
Phase III Adaptive Adaptive Stereostactic Body Radiotherapy (SBRT) With Dose Escalation for High-Risk Prostate Cancer
View on ClinicalTrials.gov
Recruiting
Back to High Risk Prostate Cancer trials
Phase III Adaptive Adaptive Stereostactic Body Radiotherapy (SBRT) With Dose Escalation for High-Risk Prostate Cancer
Not a traditional drug trial — this study doesn't follow the standard phase structure.
Trial locations
(1 site)
France
Centre Eugène Marquis, Rennes